Dr. Babak Saboury

Overview

Dr. Babak Saboury, MD, MPH, DABR, DABNM, is a physician-scientist working at the intersection of nuclear medicine, radiopharmaceutical therapy, artificial intelligence, and clinical informatics. As Co-Founder and Chief Innovation Officer at United Theranostics, he helps guide technology-enabled approaches to more personalized cancer care.

His work is grounded in molecular imaging, theranostics, quantitative imaging biomarkers, and the practical use of AI to support diagnosis, treatment planning, and radiopharmaceutical therapy optimization.

Locations

Education & Training

Dr. Saboury completed radiology residency and nuclear medicine residency training at the University of Maryland. He also completed a post-doctoral clinical research fellowship at the University of Pennsylvania.

His advanced training includes an onco-radiology and nuclear oncology fellowship through the National Institutes of Health and the University of Maryland, giving him a multidisciplinary foundation across radiology, nuclear medicine, oncology, research, and clinical imaging innovation.

Clinical Focus

Dr. Saboury’s clinical focus includes molecular imaging, theranostics, radiopharmaceutical therapy, quantitative imaging biomarkers, dosimetry, PET/MRI, PET/CT, and AI-supported imaging analysis.

At United Theranostics, his work supports patient-centered precision oncology by helping connect advanced imaging data with individualized treatment planning and clinical trial development.

Leadership & Appointments

At United Theranostics, Dr. Saboury serves as Co-Founder and Chief Innovation Officer. He also serves as Executive and Medical Director of Clinical Trials, helping oversee the design and execution of radiopharmaceutical research initiatives.

Before United Theranostics, he served at the National Institutes of Health Clinical Center, where his leadership roles included Chief Clinical Data Science Officer and Lead Radiologist for PET/MRI. His work there included initiatives in radiomics, radiogenomics, precision dosimetry, and data-driven imaging.

Research & Publications

Dr. Saboury’s research spans artificial intelligence in nuclear medicine, molecular imaging, quantitative imaging biomarkers, radiopharmaceutical therapy optimization, PET/CT, PET/MRI, and clinical trial translation.

His publication record includes work on ultra-low-dose PET protocols, computational modeling for radiopharmaceutical therapy, and the application of AI to nuclear medicine and oncologic imaging.

Professional Affiliations

Dr. Saboury is a Diplomate of the American Board of Radiology and the American Board of Nuclear Medicine. His professional work spans nuclear medicine, radiology, oncology, artificial intelligence, clinical informatics, and radiopharmaceutical therapy.

He also contributes to the broader field through editorial, advisory, and scientific work focused on nuclear medicine innovation and AI-enabled imaging.

Honors & Recognition

Dr. Saboury is recognized for his contributions to AI-enabled nuclear medicine, clinical imaging innovation, radiopharmaceutical therapy research, and quantitative imaging biomarkers.

His leadership in clinical trials, clinical data science, PET/MRI, and precision dosimetry reflects a career focused on making advanced theranostic care more personalized, measurable, and accessible.

Contact

Dr. Saboury practices through United Theranostics – Bethesda.